| 31. | Stocks rated 2 to 2 . 5 underperformed the S & AMP; P by 3 . 7 percentage points.
|
| 32. | Biogen declined $ 3.32 to $ 42.91 after Merrill Lynch lowered the drugmaker's stock rating to sell from neutral.
|
| 33. | Maryland stocks fell, dragged down by shares of Mid Atlantic Medical Services Inc ., whose stock rating was downgraded.
|
| 34. | Decliners included ChevronTexaco, which slipped 11 cents to $ 74.94, after Deutsche Securities lowered the oil company's stock rating.
|
| 35. | Biogen declined $ 3.67 to $ 42.56 after Merrill Lynch lowered the drugmaker's stock rating to sell from neutral.
|
| 36. | Biogen declined $ 1.97 to $ 44.26 after Merrill Lynch lowered the drugmaker's stock rating to sell from neutral.
|
| 37. | Conigliaro remains positive about the company's prospects, initiating a stock rating of " market outperform " two days ago.
|
| 38. | Morgan Stanley Dean Witter analyst Rebecca Runkle wrote in a report Thursday, downgrading the stock rating to neutral from outperform.
|
| 39. | Its preferred stock rating and shelf registration for preferred stock were cut to " ba3 " from " ba1 ."
|
| 40. | Intel Corp .'s estimated earnings for 1998 and its stock rating were cut by UBS Securities, cable channel CNBC reported.
|
